体细胞突变调控IgA肾病中抗半乳糖缺陷型IgA1自身抗体
该研究对7例IgA肾病患者和6例健康对照的外周血单个核细胞进行生殖系可变区基因扩增测序,发现生殖系基因编码Y1C(A/V)3序列,患者抗半乳糖缺陷型IgA1自身抗体中的A/V>S替换并非罕见生殖系变异,建模分析提示S3羟基稳定CDR3环茎结构以增强结合。
要点
- 患者抗半乳糖缺陷型IgA1自身抗体CDR3的A/V>S替换并非源于罕见生殖系基因变异。
- 生殖系可变区基因编码Y1C(A/V)3氨基酸序列。
- S3羟基可稳定CDR3环茎及邻近β折叠结构,有助于有效结合半乳糖缺陷型IgA1。
核心结论
- IgA肾病患者抗半乳糖缺陷型IgA1自身抗体CDR3区的A/V>S替换不是罕见生殖系基因变异所致。
研究设计与样本
- 研究对7例IgA肾病患者的和6例健康对照的外周血单个核细胞进行生殖系可变区基因扩增和Sanger测序。
主要发现
- 生殖系基因可变区CDR3编码Y1C(A/V)3氨基酸序列。
- 建模分析提示S3羟基横跨CDR3环茎,稳定邻近β折叠和茎结构,为有效结合半乳糖缺陷型IgA1的重要特征。
临床怎么用
- 理解导致自身抗体产生的过程可能为治疗IgA肾病提供新方法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Autoantibodies against galactose-deficient IgA1 drive formation of pathogenic immune complexes in IgA nephropathy. IgG autoantibodies against galactose-deficient IgA1 in patients with IgA nephropathy have a specific amino-acid sequence, Y1CS3, in the complementarity-determining region 3 of the heavy chain variable region compared with a Y1CA3 sequence in similar isotype-matched IgG from healthy controls. We previously found that the S3 residue is critical for binding galactose-deficient IgA1. To determine whether this difference is due to a rare germline sequence, we amplified and sequenced the corresponding germline variable region genes from peripheral blood mononuclear cells of seven patients with IgA nephropathy and six healthy controls from whom we had cloned single-cell lines secreting monoclonal IgG specific for galactose-deficient IgA1. Sanger DNA sequencing revealed that complementarity-determining region 3 in the variable region of the germline genes encoded the Y1C(A/V)3 amino-acid sequence. Thus, the A/V>S substitution in the complementarity-determining region 3 of anti-galactose-deficient-IgA1 autoantibodies of the patients with IgA nephropathy is not a rare germline gene variant. Modeling analyses indicated that the S3 hydroxyl group spans the complementarity-determining region 3 loop stem, stabilizing the adjacent β-sheet and stem structure, important features for effective binding to galactose-deficient IgA1. Understanding processes leading to production of the autoantibodies may offer new approaches to treat IgA nephropathy.
引用
- Huang ZQ, Raska M, Stewart TJ, et al. Somatic Mutations Modulate Autoantibodies against Galactose-Deficient IgA1 in IgA Nephropathy. J Am Soc Nephrol. 2016. PMID: 26966014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。